BG105010A - Medicamentous form containing paroxetine - Google Patents

Medicamentous form containing paroxetine

Info

Publication number
BG105010A
BG105010A BG105010A BG10501000A BG105010A BG 105010 A BG105010 A BG 105010A BG 105010 A BG105010 A BG 105010A BG 10501000 A BG10501000 A BG 10501000A BG 105010 A BG105010 A BG 105010A
Authority
BG
Bulgaria
Prior art keywords
form containing
containing paroxetine
medicamentous form
medicamentous
paroxetine
Prior art date
Application number
BG105010A
Other languages
Bulgarian (bg)
English (en)
Inventor
David Elder
Graham LEONARD
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105010A publication Critical patent/BG105010A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BG105010A 1998-05-13 2000-11-30 Medicamentous form containing paroxetine BG105010A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
BG105010A true BG105010A (en) 2001-07-31

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105010A BG105010A (en) 1998-05-13 2000-11-30 Medicamentous form containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077682A2 (ru)
JP (1) JP2002514591A (ru)
KR (1) KR20010043574A (ru)
CN (1) CN1308521A (ru)
AP (1) AP2000002019A0 (ru)
AU (1) AU3940999A (ru)
BG (1) BG105010A (ru)
BR (1) BR9910401A (ru)
CA (1) CA2331871A1 (ru)
EA (1) EA200001174A1 (ru)
GB (1) GB9810181D0 (ru)
HU (1) HUP0102064A2 (ru)
ID (1) ID28019A (ru)
IL (1) IL139594A0 (ru)
NO (1) NO20005683L (ru)
PL (1) PL344573A1 (ru)
SK (1) SK17142000A3 (ru)
TR (1) TR200003350T2 (ru)
WO (1) WO1999058113A2 (ru)
ZA (1) ZA200006562B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AU2002330771A1 (en) * 2001-10-22 2003-06-10 Synthon B.V. N-formyl derivatives of paroxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EA002034B1 (ru) * 1997-01-15 2001-12-24 Смитклайн Бичам Плс Композиция на основе пароксетина
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida

Also Published As

Publication number Publication date
ZA200006562B (en) 2002-02-13
GB9810181D0 (en) 1998-07-08
HUP0102064A2 (hu) 2002-05-29
ID28019A (id) 2001-05-03
WO1999058113A3 (en) 2000-02-17
NO20005683D0 (no) 2000-11-10
TR200003350T2 (tr) 2001-03-21
AP2000002019A0 (en) 2000-12-31
AU3940999A (en) 1999-11-29
BR9910401A (pt) 2001-01-09
WO1999058113A2 (en) 1999-11-18
NO20005683L (no) 2000-12-05
PL344573A1 (en) 2001-11-05
EP1077682A2 (en) 2001-02-28
SK17142000A3 (sk) 2001-06-11
EA200001174A1 (ru) 2001-06-25
IL139594A0 (en) 2002-02-10
CN1308521A (zh) 2001-08-15
CA2331871A1 (en) 1999-11-18
KR20010043574A (ko) 2001-05-25
JP2002514591A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
NZ507271A (en) Fast disintegrating tablets
MY112123A (en) Process for preparing tablets containing paroxetine
MY135183A (en) Rapidly disintegrating methylcellulose tablets
IL136831A0 (en) Process for manufacturing bite-dispersion tablets
HUP0100394A3 (en) 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
HUP0002248A3 (en) Tablets, and process for making tablets
TW200716550A (en) Pharmaceutical composition comprising ritonavir
GB8906414D0 (en) Solid,rapidly disintegrating dosage form
BG105011A (en) Composition containing paroxetine
BG105010A (en) Medicamentous form containing paroxetine
EP0858262A4 (en) THROMBIN INHIBITORS
HK1029025A1 (en) Compressed chloramine-t tablets and method for the production thereof
EP1044394A4 (en) METHOD FOR PRODUCING A RADIO-SENSITIVE COMPOSITION
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases
EP0178299A4 (en) DOSAGE FORM FOR NAPROXYN FOR PERMANENT ADMINISTRATION IN THE MOUTH.
UA41981C2 (ru) Биотиновые соединения, способ их получения, фармацевтическая композиция и способ ее получения
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
MXPA04004980A (es) Antagonistas del receptor ccr-3.
IT8820347A0 (it) Pressa per pezzi sagomati ceramici, specialmente piastrelle.
SG43753A1 (en) Novel matrix resin for high-temperature stable photoimageable compositions
EP0587566A4 (en) METHOD FOR CONVERTING CLOSTRIDIA INTO SYNCHRONIZED CELLS OF CRITICAL LENGTH OR WITH LIGHT-BREAKING ENDOSPORES.
IT1293292B1 (it) Dispositivo per l'alimentazione singolarizzata di articoli a sottostanti organi di ricevimento.
DE69717147D1 (en) Thrombin inhibitoren
HUP0203655A3 (en) Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds
HU911514D0 (en) Process for manufacturing water-resistant briquette